Tuesday, 28 May 2019 16:55

Our Privacy Policies

Written by
Monday, 25 February 2019 21:10

Homepage

Written by

Global Excellence in Animal Health

Bimeda is a leading global manufacturer, marketer and distributor of animal health products and veterinary pharmaceuticals. Through ongoing expansion and strategic acquisition, Bimeda has established markets in more than eighty countries worldwide and has R&D, manufacturing and distribution capabilities across Europe, North America, South America, Africa, Asia and Australasia. Bimeda employs over + employees worldwide and has its global headquarters in Carrickmines, Dublin, Ireland. Bimeda is focused on providing a comprehensive, customer-driven service, and selling consistently high-quality products, at a market-conscious price level.

Within Ireland, Bimeda focuses primarily on the categories of parasite control, nutrition, cattle production and equine health; providing high quality, cost-effective products to vets, animal health professionals and farmers around the country.

To learn more about Bimeda’s global presence, why not read our corporate brochure

Want to learn more about work at Bimeda, read our brochure about life at Bimeda Ireland.

Herbert Building

Monday, 21 January 2019 17:05

About Bimeda in Ireland

Written by

 

 

 

Tuesday, 04 December 2018 14:48

Contact

Written by
Airton Road

Bimeda Ireland

Bimeda Animal Health Limited

2, 3 & 4 Airton Close, Airton Road,
Tallaght, Dublin 24,
D24 FH9V
Ireland

01 4667900

sandyford innovation900

Bimeda Global Innovation Centre

21 Spruce Avenue
Stillorgan Industrial Park
Dublin 18
A94 K5C8
Ireland

ireland head office

Bimeda Group Headquarters

Floor 1B, The Herbert Building, The Park
Carrickmines,
Dublin 18
D18 K8Y4
Ireland

Customer Service Department

This email address is being protected from spambots. You need JavaScript enabled to view it.

01 466 7941

Queries For Markets Outside Of Ireland

This email address is being protected from spambots. You need JavaScript enabled to view it.

Pharmacovigilance

To report a possible adverse reaction to a Bimeda product, please contact our Pharmacovigilance Department

This email address is being protected from spambots. You need JavaScript enabled to view it.

Monday, 19 November 2018 21:36

Polyglycan - Robert Hunt

Written by

I have continued to use Polyglycan® as a standard postoperative parenteral treatment as well for essentially all of my orthopedics.
I have encountered no adverse effects either locally within the joint or any systemic reactions from either route of administration of Polyglycan®.

Robert J. Hunt, DVM, MS, Diplomate
ACVS Hagyard Equine Medical Institute, Lexington, KY

Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.

Monday, 19 November 2018 21:35

Polyglycan - Chris Morrow

Written by

We’ve used over 50,000 mL of Polyglycan® in our practice giving us a high level of comfort and confidence in its applications.
To date there have been no adverse events to be reported by our clients or our practice.
Through my peer group I have not had conversations to suggest that their experience has been different. In my opinion, application of Polyglycan® has benefitted the joint health and the overall well-being of horses that I have had the privilege to be the caregiver.

Chris Morrow, DVM
Mobile Veterinary Practice, Amarillo, TX

Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.

Monday, 19 November 2018 21:32

Polyglycan - C.R. Johnson

Written by

the findings of this study do not correlate with what I have seen in 9 years of using this product in a clinical setting, and I disagree with the conclusion that Polyglycan® may be harmful to the joint when administered IV.
Although the experimental model used in this study is the best model available for measuring changes in the joint environment using different medications, in my opinion, the model, as an acute chip fracture, does not replicate the disease process that I see in practice. Hopefully, the findings of this article will lead to new experiments & new discoveries about the processes involved with osteoarthritis.

C.R. Johnson, DVM, MS, DACVS
Equine Surgical Services, Versailles, KY

Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.

Page 9 of 11